日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial

一项针对6周至5月龄婴儿的二价诺如病毒候选疫苗的安全性和免疫原性研究：一项II期随机双盲试验

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2450878
Sáez-Llorens, Xavier; deAntonio, Rodrigo; López-Medina, Eduardo; López, Pío; Masuda, Taisei; Mendelman, Paul M; Sherwood, Jim; Baehner, Frank; Borkowski, Astrid
微生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Fabrication and Characterization of Biomedical Ti-Mg Composites via Spark Plasma Sintering

利用放电等离子烧结法制备和表征生物医用Ti-Mg复合材料

期刊:Materials
影响因子:3.2
doi:10.3390/ma17143470
Masuda, Taisei; Oh, Minho; Kobayashi, Equo
发表日期：2024
文献求助 收藏

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial

一项针对6个月至4岁儿童的二价病毒样颗粒诺如病毒候选疫苗的免疫原性和耐受性研究：一项II期随机、双盲试验

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2204787
López, Pio; López-Medina, Eduardo; Sáez-Llorens, Xavier; deAntonio, Rodrigo; Masuda, Taisei; Mendelman, Paul M; Sherwood, James; Baehner, Frank; Borkowski, Astrid
微生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial

NVX-CoV2373 (TAK-019) 单剂加强针在既往已完成 COVID-19 mRNA 疫苗基础免疫接种的健康日本成年人中的免疫原性和安全性：一项 3 期开放标签试验的主要分析报告

期刊:
影响因子:
doi:10.1016/j.vaccine.2023.05.001
Kuriyama, Kenji; Murakami, Kyoko; Masuda, Taisei; Sugiura, Kenkichi; Sakui, Sho; Schuring, Ron P; Mori, Mitsuhiro
免疫/内分泌
发表日期：2023
文献求助 收藏

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial

NVX-CoV2373 (TAK-019)疫苗在健康日本成年人中的安全性和免疫原性：一项I/II期随机对照试验的中期报告

期刊:
影响因子:
doi:10.1016/j.vaccine.2022.04.035
Masuda, Taisei; Murakami, Kyoko; Sugiura, Kenkichi; Sakui, Sho; Schuring, Ron P; Mori, Mitsuhiro
免疫/内分泌
发表日期：2022
文献求助 收藏

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report

一项针对健康日本成年人的COVID-19疫苗mRNA-1273的1/2期随机安慰剂对照研究：中期报告

期刊:
影响因子:
doi:10.1016/j.vaccine.2022.02.030
Masuda, Taisei; Murakami, Kyoko; Sugiura, Kenkichi; Sakui, Sho; Philip Schuring, Ron; Mori, Mitsuhiro
发表日期：2022
文献求助 收藏

Nationwide epidemiologic study of norovirus-related hospitalization among Japanese older adults

日本老年人诺如病毒相关住院治疗的全国流行病学研究

期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-019-4007-2
Ohfuji, Satoko; Kondo, Kyoko; Ito, Kazuya; Kase, Tetsuo; Maeda, Akiko; Fukushima, Wakaba; Masuda, Taisei; Kano, Munehide
微生物学
发表日期：2019
文献求助 收藏

Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma.

Th2 反应在过敏性哮喘小鼠模型中过敏原诱导的气道重塑发展中的作用

期刊:British Journal of Pharmacology
影响因子:7.7
doi:10.1038/sj.bjp.0705105
Komai Masato, Tanaka Hiroyuki, Masuda Taisei, Nagao Koichi, Ishizaki Masayuki, Sawada Masatsugu, Nagai Hiroichi
免疫/内分泌
哮喘
T细胞
发表日期：2003
文献求助 收藏